Dr. Pierre Kory Talks Covid-19, Ivermectin and the FLCCC
Release Date: 11/25/2020
trialsitenews's podcast
In the last few weeks, the mainstream media ran with stories about Ivermectin, most noticeably referring to it as "horse medicine" or "horse dewormer" while, for some reason, leaving out the fact that Ivermectin is a WHO essential medicine for HUMANS.
info_outline Kelly McKee from Medidata talks transforming the patient clinical trial experiencetrialsitenews's podcast
An interview with Kelly McKee from Medidata on transforming the patient clinical trial experience.
info_outline CATalyst | Indian Bar Association Serve Legal Notice on WHO's chief scientist Dr. Soumya Swaminathantrialsitenews's podcast
info_outline Ralph Lorigo Talks NY Court Rulings Over Ivermectin Use In Covid-19 Treatment | Interview
trialsitenews's podcast
We sit down with Ralph Lorigo, of the Law Office of Ralph C. Lorigo to discuss NY court cases regarding Ivermectin and Covid-19.
info_outline Ralph Lorigo Talks NY Court Rulings Over Ivermectin Use In Covid-19 Treatment | Interviewtrialsitenews's podcast
We sit down with Ralph Lorigo, of the Law Office of Ralph C. Lorigo to discuss NY court cases regarding Ivermectin and Covid-19.
info_outline Shabnam Palesa Mohamed, discusses state of Ivermectin in South Africa | Podcasttrialsitenews's podcast
Shabnam Palesa Mohamed: Activist. journalist, mediator (LLB). Founder of SAHARI and THJ CEO, discusses state of Ivermectin in South Africa. We discuss the twists and turns of the legality issues of the drug, to a campaign to bring awareness through-out the country and beyond.
info_outline Dr. Kedar discusses Covid-19 impact on bringing research to rural communitiestrialsitenews's podcast
We talk with Dr. Kedar about rural research initiatives and the impact Covid-19 has had in bringing advanced research to them. Dr. Kedar specializes in autoimmune diseases that effect the musculoskeletal system, such as rheumatism, arthritis, and other disorders of the joints, muscles and ligaments.
info_outline Melanie Rice: Patient Suffering from MS discusses her experience with the diseasetrialsitenews's podcast
Melanie Rice who is suffering from Multiple Sclerosis. She was diagnosed Sept 20 2019 at the Mayo Clinic in Jacksonville Florida. Since then she has uncovered an entire community, or more appropriately, a family of thousands of people struggling with this autoimmune disease. She has become an advocate for MS patients, and so we have brought her on to talk with us about her illness.
info_outline Sam Searcy Talks Accelerating The Clinical Trials Process With Cloud-Based Service Providerstrialsitenews's podcast
We sit down with Sam Searcy to talk about his Company Clinistart, and innovative cloud-based service providers designed to accelerate clinical trial site activation and study start up. The goal: accelerate each step of the clinical trials process to accelerate the availability of medicines sooner for patients.
info_outline Dr. John Boockvar Of Lenox Hill Hospital Talks New Surgical Technique To Treat Glioblastomatrialsitenews's podcast
We sit down for an interview with Dr. John Boockvar, vice chair of neurosurgery at Lenox Hill Hospital, who started a first-in-human clinical research study involving a new surgical technique to treat glioblastoma multiforme (GBM) - the most aggressive form of brain cancer.
info_outlineDr. Pierre Kory Talks Covid-19, Ivermectin and the FLCCC:
Dr. Pierre Kory, Associate Professor of Medicine at St. Luke’s Aurora Medical Center and who TrialSite News would classify as a Pulmonologist and ICU specialist dedicated completely to the COVID-19 patient. He has been a shining light in what can be a dark and murky time in his intense commitment to treat and ensure patients are safe from this pandemic. He was educated at the St. George University Medical School at and has been board certified by the American Board of Internal Medicine in Internal Medicine, Pulmonary Disease and Critical Care Medicine. Now, Recently the topic of a TrialSite News article, Dr. Kory is an active contributor to real world-based COVID-19 protocols based on extensive, unfolding and rich evidence from the clinic during the pandemic. One alliance known as the FLCCC is a topic of discussion today.